SAT630 Analytical Validation Of A Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay

Disclosure: P. Iyer: None. R. Dadu: Advisory Board Member; Self; Exelixis, Inc., Bayer, Inc. Research Investigator; Self; Merck, Exelixis, Inc., AstraZeneca. A. Barque: Employee; Self; Veracyte, Inc. Stock Owner; Self; Veracyte, Inc. Z. Cleslei: Employee; Self; Veracyte, Inc. Stock Owner; Self; Vera...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Priyanka, Dadu, Ramona, Barque, Anna, Cleslei, Zanelli, Jiang, Huimin, Walsh, Sean, Zheng, Xingyu, Hao, Yangyang, Huang, Jing, Klopper, Joshua P, Kloos, Richard T, Cabanillas, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554516/
http://dx.doi.org/10.1210/jendso/bvad114.2200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554516/
http://dx.doi.org/10.1210/jendso/bvad114.2200

Ejemplares similares